Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532.
Article
Google Scholar
Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–37.
Article
CAS
Google Scholar
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998;95(11):6460–4.
Article
CAS
Google Scholar
Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, et al. The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science. 2012;336(6085):1168–71.
Article
CAS
Google Scholar
Wang H, Kulas JA, Wang C, Holtzman DM, Ferris HA, Hansen SB. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci U S A. 2021;118(33):e2102191118.
Article
CAS
Google Scholar
Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;28(1):75–80.
Article
CAS
Google Scholar
Reitz C. Dyslipidemia and the risk of Alzheimer’s disease. Curr Atheroscler Rep. 2013;15(3):307.
Article
Google Scholar
Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12(2):105–12.
Article
CAS
Google Scholar
Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93(18):9799–804.
Article
CAS
Google Scholar
Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39(8):1594–600.
Article
CAS
Google Scholar
Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A. 1999;96(13):7238–43.
Article
CAS
Google Scholar
Brown J 3rd, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, et al. Differential expression of cholesterol hydroxylases in Alzheimer’s disease. J Biol Chem. 2004;279(33):34674–81.
Article
CAS
Google Scholar
Bogdanovic N, Bretillon L, Lund EG, Diczfalusy U, Lannfelt L, Winblad B, et al. On the turnover of brain cholesterol in patients with Alzheimer’s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett. 2001;314(1–2):45–8.
Article
CAS
Google Scholar
Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem. 2003;278(25):22980–8.
Article
CAS
Google Scholar
Varma VR, Büşra Lüleci H, Oommen AM, Varma S, Blackshear CT, Griswold ME, et al. Abnormal brain cholesterol homeostasis in Alzheimer’s disease-a targeted metabolomic and transcriptomic study. NPJ Aging Mech Dis. 2021;7(1):11.
Article
CAS
Google Scholar
Testa G, Staurenghi E, Zerbinati C, Gargiulo S, Iuliano L, Giaccone G, et al. Changes in brain oxysterols at different stages of Alzheimer’s disease: their involvement in neuroinflammation. Redox Biol. 2016;10:24–33.
Article
CAS
Google Scholar
Bjorkhem I, Andersson U, Ellis E, Alvelius G, Ellegard L, Diczfalusy U, et al. From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem. 2001;276(40):37004–10.
CAS
Google Scholar
Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, et al. Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004;42(2):186–91.
Article
CAS
Google Scholar
Bretillon L, Lutjohann D, Stahle L, Widhe T, Bindl L, Eggertsen G, et al. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res. 2000;41(5):840–5.
Article
CAS
Google Scholar
Leoni V, Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie. 2013;95(3):595–612.
Article
CAS
Google Scholar
Mast N, Li Y, Linger M, Clark M, Wiseman J, Pikuleva IA. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J Biol Chem. 2014;289(6):3529–38.
Article
CAS
Google Scholar
Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129–40.
Article
CAS
Google Scholar
Mast N, Saadane A, Valencia-Olvera A, Constans J, Maxfield E, Arakawa H, et al. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer’s disease. Neuropharmacology. 2017;123:465–76.
Article
CAS
Google Scholar
Petrov AM, Lam M, Mast N, Moon J, Li Y, Maxfield E, et al. CYP46A1 Activation by efavirenz leads to behavioral improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice. Neurotherapeutics. 2019;16(3):710–24.
Article
CAS
Google Scholar
Petrov AM, Mast N, Li Y, Pikuleva IA. The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment. FASEB J. 2019;33(8):8782–98.
Article
CAS
Google Scholar
Petrov AM, Mast N, Li Y, Denker J, Pikuleva IA. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes. Brain Commun. 2020;2(1):fcaa043.
Article
Google Scholar
Mast N, Petrov AM, Prendergast E, Bederman I, Pikuleva IA. Brain acetyl-CoA production and phosphorylation of cytoskeletal proteins are targets of CYP46A1 activity modulation and altered sterol flux. Neurotherapeutics. 2021;18(3):2040–60.
Article
CAS
Google Scholar
Mast N, Li Y, Pikuleva IA. Increased acetylcholine levels and other brain effects in 5XFAD mice after treatment with 8,14-dihydroxy metabolite of efavirenz. Int J Mol Sci. 2022;23(14):7669.
Article
CAS
Google Scholar
Pikuleva IA. Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases. Explor Neuroprotective Ther. 2021;1(3):159–72.
Google Scholar
Pikuleva IA, Cartier N. Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of action to clinical applications. Front Aging Neurosci. 2021;13(400):696778.
Article
CAS
Google Scholar
El-Darzi N, Mast N, Buchner DA, Saadane A, Dailey B, Trichonas G, et al. Low-dose anti-HIV drug efavirenz mitigates retinal vascular lesions in a mouse model of Alzheimer’s disease. Front Pharmacol. 2022;13:902254.
Article
CAS
Google Scholar
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–61.
Article
CAS
Google Scholar
Dietschy JM, Turley SD. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004;45(8):1375–97.
Article
CAS
Google Scholar
Dietschy JM. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol Chem. 2009;390(4):287–93.
Article
CAS
Google Scholar
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
Article
CAS
Google Scholar
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72.
Article
CAS
Google Scholar
Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, et al. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012;122(9):3159–69.
Article
CAS
Google Scholar
Lee WN, Bassilian S, Guo Z, Schoeller D, Edmond J, Bergner EA, et al. Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. Am J Physiol. 1994;266(3 Pt 1):E372–83.
CAS
Google Scholar
Lin JB, Mast N, Bederman IR, Li Y, Brunengraber H, Bjorkhem I, et al. Cholesterol in mouse retina originates primarily from in situ de novo biosynthesis. J Lipid Res. 2016;57(2):258–64.
Article
CAS
Google Scholar
Mast N, Reem R, Bederman I, Huang S, DiPatre PL, Björkhem I, et al. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Invest Ophthalmol Vis Sci. 2011;52(1):594–603.
Article
CAS
Google Scholar
Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem. 1995;225(1):73–80.
Article
CAS
Google Scholar
Li M, Wang W, Li Y, Wang L, Shen X, Tang Z. CYP46A1 intron-2T/C polymorphism and Alzheimer’s disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls. Neurosci Lett. 2013;549:18–23.
Article
CAS
Google Scholar
Apostolova N, Funes HA, Blas-Garcia A, Galindo MJ, Alvarez A, Esplugues JV. Efavirenz and the CNS: what we already know and questions that need to be answered. J Antimicrob Chemother. 2015;70(10):2693–708.
Article
CAS
Google Scholar
Dalwadi DA, Ozuna L, Harvey BH, Viljoen M, Schetz JA. Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs. Pharmacol Rev. 2018;70(3):684–711.
Article
CAS
Google Scholar
London IM, Rittenberg D. Deuterium studies in normal man. I. The rate of synthesis of serum cholesterol. II. Measurement of total body water and water absorption. J Biol Chem. 1950;184(2):687–91.
Article
CAS
Google Scholar
Jones PJ, Leitch CA, Li ZC, Connor WE. Human cholesterol synthesis measurement using deuterated water. Theoretical and procedural considerations. Arterioscler Thromb Vasc Biol. 1993;13(2):247–53.
Article
CAS
Google Scholar
Dietschy JM, Spady DK. Measurement of rates of cholesterol synthesis using tritiated water. J Lipid Res. 1984;25(13):1469–76.
Article
CAS
Google Scholar
Thelen KM, Laaksonen R, Päivä H, Lehtimäki T, Lütjohann D. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol. 2006;46(7):812–6.
Article
CAS
Google Scholar
Nemaura T, Nhachi C, Masimirembwa C. Impact of gender, weight and CYP2B6 genotype on efavirenz exposure in patients on HIV/AIDS and TB treatment: Implications for individualising therapy. Afr J Pharm Pharmacol. 2012;6(29):2188–93.
CAS
Google Scholar
Jones PJ. Use of deuterated water for measurement of short-term cholesterol synthesis in humans. Can J Physiol Pharmacol. 1990;68(7):955–9.
Article
CAS
Google Scholar